· patients whose diseases would otherwise be untreatable and probably terminal. Its use has...

12

Transcript of  · patients whose diseases would otherwise be untreatable and probably terminal. Its use has...

Page 1:  · patients whose diseases would otherwise be untreatable and probably terminal. Its use has extended beyond treatment for leukaemia, aplastic anaemia, and severe combined immune
Page 2:  · patients whose diseases would otherwise be untreatable and probably terminal. Its use has extended beyond treatment for leukaemia, aplastic anaemia, and severe combined immune
Page 3:  · patients whose diseases would otherwise be untreatable and probably terminal. Its use has extended beyond treatment for leukaemia, aplastic anaemia, and severe combined immune
Page 4:  · patients whose diseases would otherwise be untreatable and probably terminal. Its use has extended beyond treatment for leukaemia, aplastic anaemia, and severe combined immune
Page 5:  · patients whose diseases would otherwise be untreatable and probably terminal. Its use has extended beyond treatment for leukaemia, aplastic anaemia, and severe combined immune
Page 6:  · patients whose diseases would otherwise be untreatable and probably terminal. Its use has extended beyond treatment for leukaemia, aplastic anaemia, and severe combined immune
Page 7:  · patients whose diseases would otherwise be untreatable and probably terminal. Its use has extended beyond treatment for leukaemia, aplastic anaemia, and severe combined immune
Page 8:  · patients whose diseases would otherwise be untreatable and probably terminal. Its use has extended beyond treatment for leukaemia, aplastic anaemia, and severe combined immune
Page 9:  · patients whose diseases would otherwise be untreatable and probably terminal. Its use has extended beyond treatment for leukaemia, aplastic anaemia, and severe combined immune
Page 10:  · patients whose diseases would otherwise be untreatable and probably terminal. Its use has extended beyond treatment for leukaemia, aplastic anaemia, and severe combined immune
Page 11:  · patients whose diseases would otherwise be untreatable and probably terminal. Its use has extended beyond treatment for leukaemia, aplastic anaemia, and severe combined immune
Page 12:  · patients whose diseases would otherwise be untreatable and probably terminal. Its use has extended beyond treatment for leukaemia, aplastic anaemia, and severe combined immune